Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
暂无分享,去创建一个
Rainer Fietkau | Werner Hohenberger | Peter Martus | Christian Wittekind | Claus Rödel | W. Hohenberger | C. Rödel | R. Sauer | R. Fietkau | P. Martus | L. Füzesi | C. Wittekind | M. Klimpfinger | T. Liersch | Thomas Papadoupolos | Laszlo Füzesi | Martin Klimpfinger | Torsten Liersch | Rudolf Raab | Rolf Sauer | R. Raab | Thomas Papadoupolos
[1] J. Guillem,et al. Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection , 2004, Diseases of the colon and rectum.
[2] K. Tveit,et al. Randomized controlled trial of postoperative radiotherapy and short‐term time‐scheduled 5‐fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer , 1997 .
[3] P. Adeleine,et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Vauthey,et al. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. , 2002, Journal of the American College of Surgeons.
[5] J. Ajani,et al. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. , 1999, Annals of surgery.
[6] S. Andreola,et al. Pathological features of rectal cancer after preoperative radiochemotherapy , 1998, International Journal of Colorectal Disease.
[7] Prolongation of the disease-free interval in surgically treated rectal carcinoma. , 1985, The New England journal of medicine.
[8] J. Petiot,et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.
[9] I. Nagtegaal,et al. High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients. , 2003, International journal of radiation oncology, biology, physics.
[10] E. Thomas,et al. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] C. Rödel,et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. , 2002, International journal of radiation oncology, biology, physics.
[12] F. Guillemin,et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. , 1998, International journal of radiation oncology, biology, physics.
[13] P. Romestaing,et al. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors? , 2005, International journal of radiation oncology, biology, physics.
[14] L. Ellis,et al. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma , 2007, Journal of Gastrointestinal Surgery.
[15] Arief Suriawinata,et al. Patterns of Morphologic Alteration in Residual Rectal Carcinoma Following Preoperative Chemoradiation and Their Association With Long-term Outcome , 2004, The American journal of surgical pathology.
[16] C. Taylor,et al. T-Level Downstaging and Complete Pathologic Response After Preoperative Chemoradiation for Advanced Rectal Cancer Result in Decreased Recurrence and Improved Disease-Free Survival , 2002, Diseases of the colon and rectum.
[17] B. Warren,et al. Quantification of Histologic Regression of Rectal Cancer After Irradiation , 2002, Diseases of the colon and rectum.
[18] C. Rödel,et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. , 2005, Cancer research.
[19] P. Coucke,et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy , 2002, Cancer.
[20] C. Compton,et al. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. , 1995, International journal of radiation oncology, biology, physics.
[21] W. Hohenberger,et al. Adjuvant versus Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer A Progress Report of a Phase-III Randomized Trial (Protocol CAO/ARO/AIO-94) , 2001, Strahlentherapie und Onkologie.
[22] R. Pazdur,et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. , 1999, International journal of radiation oncology, biology, physics.
[23] T. Yeatman,et al. Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation , 2001, Annals of surgery.
[24] J. Fleshman,et al. Neoadjuvant Therapy for Rectal Cancer: Histologic Response of the Primary Tumor Predicts Nodal Status , 2004, Diseases of the colon and rectum.
[25] Xiao-Feng Sun,et al. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[26] J. Holzner,et al. Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy , 1989, Cancer.
[27] G. Williams,et al. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[28] H. Höfler,et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy , 2003, Cancer.
[29] M. Bonnen,et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. , 2001, International journal of radiation oncology, biology, physics.
[30] J. Dunst,et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] W. Regine,et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. , 2000, International journal of radiation oncology, biology, physics.
[32] E. Hannisdal,et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. , 1997, The British journal of surgery.
[33] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[34] E. Venkatraman,et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. , 2005, International journal of radiation oncology, biology, physics.